Cognitive Behavioral Therapy, Sertraline, or a Combination in Childhood Anxiety

Author(s):  
David Saunders ◽  
Andres Martin ◽  
Jerome H. Taylor

This chapter provides a summary of a landmark study evaluating the treatment of anxiety disorders in child and adolescent psychiatry. Is sertraline in combination with cognitive behavioral therapy more effective than monotherapy with either treatment alone in children with anxiety disorders? Also, how do these treatments compare with placebo therapy? Starting with these questions, it describes the basics of the study, including funding, study location, who was studied, how many patients, study design, study intervention, follow-up, endpoints, results, and criticism and limitations. The chapter briefly reviews other relevant studies and information, discusses implications, and concludes with a relevant clinical case.

Author(s):  
Amanda Sun ◽  
Tobias Wasser

This chapter provides a summary of a landmark study on anxiety disorders and the roles of psychotherapy and psychopharmacology in their treatment. When treating adults with panic disorder, is imipramine in combination with cognitive behavioral therapy more effective than monotherapy with either treatment alone? Furthermore, what is the durability and tolerability of their responses? Starting with these questions, it describes the basics of the study, including funding, study location, who was studied, how many patients, study design, study intervention, follow-up, endpoints, results, and criticism and limitations. The chapter briefly reviews other relevant studies and information, discusses implications, and concludes with a relevant clinical case.


Author(s):  
Robert Ross ◽  
Rajesh R. Tampi

This chapter provides a summary of a landmark study on short and longterm treatment of insomnia. Should older patients with insomnia be managed with cognitive behavioral therapy, benzodiazepines, or both? Starting with that question, it describes the basics of the study, including funding, study location, who was studied, how many patients, study design, study intervention, follow-up, endpoints, results, and criticism and limitations. The chapter briefly reviews other relevant studies and information, discusses implications, and concludes with a relevant clinical case. The study shows that bensodiazepines and cognitive behavioral therapy are equally effective for shorterm treatment of insomnia in otherwise healthy elderly participants but cognitive behavioral therapy is far more effective for longterm treatment of insomnia.


Author(s):  
Erin Habecker ◽  
Tobias Wasser

This chapter provides a summary of a landmark study on anxiety disorders. For generalized social phobia, are fluoxetine and comprehensive cognitive behavioral therapy efficacious? How do their efficacies compare? And is there an advantage to combination therapy? Starting with these questions, it describes the basics of the study, including funding, study location, who was studied, how many patients, study design, study intervention, follow-up, endpoints, results, and criticism and limitations. Results of the study indicate that fluoxetine and comprehensive cognitive behavioral therapy are superior to placebo for the treatment of generalized social phobia; neither treatment is superior to the other and there is no apparent advantage to combination therapy. The chapter briefly reviews other relevant studies and information, discusses implications, and concludes with a relevant clinical case.


Author(s):  
Zachary Engler ◽  
Zheala Qayyum

This chapter provides a summary of a landmark study in child and adolescent psychiatry. This study is also notable for addressing the relationship between suicidal thinking and behavior and treatment of depression in adolescents. Among adolescents with depression, is fluoxetine and cognitive behavioral therapy efficacious? If so, how does the efficacy of these treatments compare with each other and in combination? Starting with these questions, it describes the basics of the study, including funding, study location, who was studied, how many patients, study design, study intervention, follow-up, endpoints, results, and criticism and limitations. The chapter briefly reviews other relevant studies and information, discusses implications, and concludes with a relevant clinical case.


2020 ◽  
Vol 51 (1) ◽  
pp. 69-84 ◽  
Author(s):  
Jennifer S. Silk ◽  
Gede Pramana ◽  
Stefanie L. Sequeira ◽  
Oliver Lindhiem ◽  
Philip C. Kendall ◽  
...  

2010 ◽  
Vol 38 (5) ◽  
pp. 683-694 ◽  
Author(s):  
Juliette Margo Liber ◽  
Brigit M. van Widenfelt ◽  
Adelinde J. M. van der Leeden ◽  
Arnold W. Goedhart ◽  
Elisabeth M. W. J. Utens ◽  
...  

Author(s):  
Stephanie Ng ◽  
Andres Martin

This chapter provides a summary of a landmark study in child and adolescent psychiatry. In medication-naïve children and adolescents with bipolar I disorder who have had a recent manic or mixed phase episode, should risperidone, lithium, or divalproex sodium be used for initial treatment? Also, for partial responders or nonresponders to the first medication, which agent should be added on or switched to? Starting with these questions, it describes the basics of the study, including funding, study location, who was studied, how many patients, study design, study intervention, follow-up, endpoints, results, and criticism and limitations. The chapter briefly reviews other relevant studies and information, discusses implications, and concludes with a relevant clinical case.


Sign in / Sign up

Export Citation Format

Share Document